Inflammatory Cell Infiltration of Adrenals in COVID-19

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was originated in November–December 2019 in Wuhan, China, and has rapidly spread around the world causing severe health and socioeconomical damage to the entire civilization. The key feature of coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is upper respiratory tract infection, which may be complicated by bilateral pneumonia. Angiotensin converting enzyme 2 (ACE2) has been identified as a key host factor, required for virus entry into cells. Interestingly, ACE2 is expressed not only in the respiratory system, but also in the other organs and systems including adrenal glands. Here we provide the first description of the pathomorphological changes in adrenal glands in patients with severe COVID-19 characterized by perivascular infiltration of CD3+ and CD8+ T-lymphocytes. Due to the central role of the adrenals in the stress response of the organism, this finding is of potential clinical relevance, because infection with the SARS-CoV-2 virus might critically impair adrenal function under pathophysiological conditions.

Key words

ACE2 - adrenal - infiltrations - COVID-19

Publication History

Received: 05 May 2020

Accepted: 01 June 2020

Article published online:
06 July 2020

• References

• 1 Su H, Yang M, Wan C. et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020;
• 2 Varga Z, Flammer AJ, Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395: 1417-1418
• 3 Bornstein SR, Rubino F, Khunti K. et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol 2020;
• 4 Bornstein SR, Dalan R, Hopkins D. et al. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol 2020; 16: 297-298
• 5 Li MY, Li L, Zhang Y. et al. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020; 9: 45
• 6 Ding Y, He L, Zhang Q. et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. J Pathol 2004; 203: 622-630
• 7 Wenham C, Smith J, Morgan R. et al. COVID-19: The gendered impacts of the outbreak. Lancet 2020; 395: 846-848
• 8 Bornstein SR. Predisposing factors for adrenal insufficiency. N Engl J Med 2009; 360: 2328-2339
• 9 Zinserling AV, Aksenov OA, Melnikova VF. et al. Extrapulmonary lesions in influenza. Tohoku J Exp Med 1983; 140: 259-272
• 10 Zinserling AV, Zinserling VA. Modern Infections: Pathologic Anatomy and Issues of Pathogenesis. Manual. 2^nd ed. Spb, Sotis; 2002: 352
• 11 Leow MK, Kwek DS, Ng AW. et al. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 2005; 63: 197-202
• 12 Bornstein SR, Bornstein TD, Andoniadou CL. Novel medications inducing adrenal insufficiency. Nat Rev Endocrinol 2019; 15: 561-562
• 13 Steenblock C, Todorov V, Kanczkowski W. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol Psychiatr 2020;